What is Graph?
Graph operates at the critical intersection of artificial intelligence and healthcare compliance. The company's AI-driven platform is engineered to unify and streamline complex safety workflows, encompassing adverse event intake, meticulous case processing, regulatory reporting, and robust risk management. By providing a comprehensive solution, Graph empowers pharma, biotech, and medical device companies to navigate the stringent regulatory landscape with greater efficiency and accuracy, ultimately bolstering patient safety.
How much funding has Graph raised?
Graph has raised a total of $3M across 1 funding round:
Seed
$3M
Seed (2025): $3M with participation from Bessemer Venture Partners
Key Investors in Graph
Bessemer Venture Partners
Bessemer Venture Partners is a prominent venture capital firm with a long history, known for its investments across various sectors and geographies. Their involvement suggests a belief in Graph's long-term growth potential and market disruption capabilities.
What's next for Graph?
The recent major strategic investment signals a new phase of growth and development for Graph. With substantial backing, the company is poised to expand its technological capabilities, enhance its market reach, and further solidify its position as a leader in AI-powered healthcare compliance. This capital will likely fuel innovation in its AI algorithms, broaden its service offerings, and enable strategic partnerships to address evolving industry needs. The company's trajectory suggests a focus on scaling its enterprise-level solutions and driving deeper integration within the global life sciences ecosystem.
See full Graph company page
